nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—MAPK3—artery—intracranial aneurysm	0.0585	0.166	CbGeAlD
Sulindac—MAPK3—Signal Transduction of S1P Receptor—ASAH1—intracranial aneurysm	0.044	0.0681	CbGpPWpGaD
Sulindac—PTGDR2—cerebellum—intracranial aneurysm	0.0319	0.0902	CbGeAlD
Sulindac—MAPK3—Ceramide signaling pathway—ASAH1—intracranial aneurysm	0.0261	0.0404	CbGpPWpGaD
Sulindac—PTGDR2—brain—intracranial aneurysm	0.0259	0.0733	CbGeAlD
Sulindac—MAPK3—Advanced glycosylation endproduct receptor signaling—AGER—intracranial aneurysm	0.0242	0.0375	CbGpPWpGaD
Sulindac—AKR1B1—medulla oblongata—intracranial aneurysm	0.024	0.0678	CbGeAlD
Sulindac—AKR1B1—midbrain—intracranial aneurysm	0.0219	0.062	CbGeAlD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.0195	0.0302	CbGpPWpGaD
Sulindac—MAPK3—medulla oblongata—intracranial aneurysm	0.0174	0.0491	CbGeAlD
Sulindac—PPARD—midbrain—intracranial aneurysm	0.0172	0.0487	CbGeAlD
Sulindac—AKR1B1—cerebellum—intracranial aneurysm	0.017	0.0479	CbGeAlD
Sulindac—PTGS1—artery—intracranial aneurysm	0.0159	0.045	CbGeAlD
Sulindac—MAPK3—midbrain—intracranial aneurysm	0.0159	0.0449	CbGeAlD
Sulindac—PTGS2—artery—intracranial aneurysm	0.0152	0.043	CbGeAlD
Sulindac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0146	0.0225	CbGpPWpGaD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—CTSK—intracranial aneurysm	0.0143	0.0221	CbGpPWpGaD
Sulindac—AKR1B1—brain—intracranial aneurysm	0.0138	0.0389	CbGeAlD
Sulindac—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0135	0.0209	CbGpPWpGaD
Sulindac—PPARD—cerebellum—intracranial aneurysm	0.0133	0.0377	CbGeAlD
Sulindac—MAPK3—IL-6 signaling pathway—TIMP1—intracranial aneurysm	0.0132	0.0204	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—SLC25A16—intracranial aneurysm	0.0131	0.0203	CbGpPWpGaD
Sulindac—MAPK3—Osteopontin Signaling—MMP9—intracranial aneurysm	0.0124	0.0192	CbGpPWpGaD
Sulindac—MAPK3—cerebellum—intracranial aneurysm	0.0123	0.0347	CbGeAlD
Sulindac—PTGDR2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0113	0.0174	CbGpPWpGaD
Sulindac—PPARD—brain—intracranial aneurysm	0.0108	0.0306	CbGeAlD
Sulindac—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0107	0.0166	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—STARD13—intracranial aneurysm	0.0102	0.0158	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.0102	0.0157	CbGpPWpGaD
Sulindac—MAPK3—brain—intracranial aneurysm	0.00998	0.0282	CbGeAlD
Sulindac—MAPK3—Endothelins—EDNRA—intracranial aneurysm	0.00998	0.0154	CbGpPWpGaD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00964	0.0149	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—ASAH1—intracranial aneurysm	0.0087	0.0135	CbGpPWpGaD
Sulindac—MAPK3—Osteopontin-mediated events—MMP2—intracranial aneurysm	0.00825	0.0128	CbGpPWpGaD
Sulindac—MAPK3—VEGFR1 specific signals—NOS3—intracranial aneurysm	0.00815	0.0126	CbGpPWpGaD
Sulindac—SLC22A6—brain—intracranial aneurysm	0.00764	0.0216	CbGeAlD
Sulindac—MAPK3—GMCSF-mediated signaling events—CCL2—intracranial aneurysm	0.00753	0.0116	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00734	0.0114	CbGpPWpGaD
Sulindac—MAPK3—Syndecan-2-mediated signaling events—MMP2—intracranial aneurysm	0.00732	0.0113	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—CTSS—intracranial aneurysm	0.00732	0.0113	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00707	0.0109	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.00692	0.0107	CbGpPWpGaD
Sulindac—PPARD—NRF2 pathway—AGER—intracranial aneurysm	0.00685	0.0106	CbGpPWpGaD
Sulindac—MAPK3—TWEAK Signaling Pathway—CCL2—intracranial aneurysm	0.0068	0.0105	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—CTSK—intracranial aneurysm	0.00673	0.0104	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—AGER—intracranial aneurysm	0.0066	0.0102	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—NCF1—intracranial aneurysm	0.00653	0.0101	CbGpPWpGaD
Sulindac—MAPK3—Osteopontin-mediated events—MMP9—intracranial aneurysm	0.0062	0.00959	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 Mediated Induction of proinflammatory cytokines—AGER—intracranial aneurysm	0.00596	0.00923	CbGpPWpGaD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—MMP2—intracranial aneurysm	0.00563	0.00871	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—CTSB—intracranial aneurysm	0.00557	0.00863	CbGpPWpGaD
Sulindac—MAPK3—IL-1 signaling pathway—CCL2—intracranial aneurysm	0.00548	0.00848	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—NCF1—intracranial aneurysm	0.00545	0.00844	CbGpPWpGaD
Sulindac—MAPK3—MyD88 cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00539	0.00835	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—intracranial aneurysm	0.00534	0.00827	CbGpPWpGaD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—NOS3—intracranial aneurysm	0.00527	0.00816	CbGpPWpGaD
Sulindac—MAPK3—Syndecan-1-mediated signaling events—MMP9—intracranial aneurysm	0.00527	0.00815	CbGpPWpGaD
Sulindac—MAPK3—MyD88 dependent cascade initiated on endosome—AGER—intracranial aneurysm	0.00525	0.00812	CbGpPWpGaD
Sulindac—PPARD—Ectoderm Differentiation—CCL2—intracranial aneurysm	0.00514	0.00796	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 9 (TLR9) Cascade—AGER—intracranial aneurysm	0.00506	0.00783	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.005	0.00774	CbGpPWpGaD
Sulindac—MAPK3—MyD88:Mal cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00498	0.0077	CbGpPWpGaD
Sulindac—MAPK3—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.00493	0.00763	CbGpPWpGaD
Sulindac—MAPK3—TWEAK Signaling Pathway—MMP9—intracranial aneurysm	0.00486	0.00752	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.0048	0.00742	CbGpPWpGaD
Sulindac—MAPK3—MyD88-independent cascade—AGER—intracranial aneurysm	0.00478	0.00739	CbGpPWpGaD
Sulindac—ALB—brain—intracranial aneurysm	0.00476	0.0135	CbGeAlD
Sulindac—PPARD—Metabolism—SLC25A16—intracranial aneurysm	0.00476	0.00736	CbGpPWpGaD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00475	0.00735	CbGpPWpGaD
Sulindac—PTGS2—medulla oblongata—intracranial aneurysm	0.00452	0.0128	CbGeAlD
Sulindac—MAPK3—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.00451	0.00697	CbGpPWpGaD
Sulindac—MAPK3—Activated TLR4 signalling—AGER—intracranial aneurysm	0.0043	0.00665	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.00422	0.00653	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00415	0.00642	CbGpPWpGaD
Sulindac—PTGS2—midbrain—intracranial aneurysm	0.00413	0.0117	CbGeAlD
Sulindac—MAPK3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.00412	0.00638	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.00404	0.00625	CbGpPWpGaD
Sulindac—MAPK3—FGF signaling pathway—MMP9—intracranial aneurysm	0.00398	0.00615	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—TIMP1—intracranial aneurysm	0.00386	0.00598	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—NOS3—intracranial aneurysm	0.00381	0.0059	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00377	0.00583	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.00374	0.00578	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00368	0.0057	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—CCL2—intracranial aneurysm	0.00363	0.00562	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—CCL2—intracranial aneurysm	0.00362	0.0056	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.0036	0.00557	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00356	0.00551	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—RBBP8—intracranial aneurysm	0.00355	0.00549	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.00339	0.00524	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.00324	0.00501	CbGpPWpGaD
Sulindac—PTGS2—cerebellum—intracranial aneurysm	0.00319	0.00903	CbGeAlD
Sulindac—PPARD—Metabolism—ASAH1—intracranial aneurysm	0.00315	0.00487	CbGpPWpGaD
Sulindac—CYP1A1—brain—intracranial aneurysm	0.00309	0.00873	CbGeAlD
Sulindac—MAPK3—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00298	0.0046	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00298	0.0046	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STARD13—intracranial aneurysm	0.00293	0.00453	CbGpPWpGaD
Sulindac—MAPK3—Disease—SLC25A16—intracranial aneurysm	0.0029	0.00449	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00287	0.00444	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00282	0.00436	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.0028	0.00433	CbGpPWpGaD
Sulindac—PTGS1—brain—intracranial aneurysm	0.00271	0.00767	CbGeAlD
Sulindac—MAPK3—Signaling by VEGF—NOS3—intracranial aneurysm	0.00271	0.00419	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00271	0.00419	CbGpPWpGaD
Sulindac—PTGS2—brain—intracranial aneurysm	0.00259	0.00733	CbGeAlD
Sulindac—MAPK3—Innate Immune System—CTSS—intracranial aneurysm	0.00237	0.00367	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NCF1—intracranial aneurysm	0.00236	0.00365	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—CCL2—intracranial aneurysm	0.00228	0.00353	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00224	0.00346	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EDNRA—intracranial aneurysm	0.00223	0.00344	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CTSK—intracranial aneurysm	0.00218	0.00338	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00215	0.00332	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00213	0.00329	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00191	0.00295	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—CCL2—intracranial aneurysm	0.00186	0.00287	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.00185	0.00286	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TIMP1—intracranial aneurysm	0.00184	0.00284	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC25A16—intracranial aneurysm	0.00182	0.00281	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—NOS3—intracranial aneurysm	0.00181	0.00281	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00181	0.0028	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CTSB—intracranial aneurysm	0.00181	0.00279	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00177	0.00274	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00174	0.00269	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC25A16—intracranial aneurysm	0.00172	0.00267	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00171	0.00265	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC25A16—intracranial aneurysm	0.00144	0.00223	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTSS—intracranial aneurysm	0.00138	0.00214	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC25A16—intracranial aneurysm	0.00128	0.00198	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTSK—intracranial aneurysm	0.00127	0.00197	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00127	0.00196	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP2—intracranial aneurysm	0.00126	0.00195	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00122	0.00188	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ASAH1—intracranial aneurysm	0.0012	0.00186	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC25A16—intracranial aneurysm	0.00117	0.00181	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—AGER—intracranial aneurysm	0.00117	0.0018	CbGpPWpGaD
Sulindac—MAPK3—Disease—CST3—intracranial aneurysm	0.00111	0.00172	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CCL2—intracranial aneurysm	0.0011	0.0017	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00108	0.00167	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTSB—intracranial aneurysm	0.00105	0.00163	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NCF1—intracranial aneurysm	0.00105	0.00162	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NOS3—intracranial aneurysm	0.000978	0.00151	CbGpPWpGaD
Sulindac—MAPK3—Disease—NCF1—intracranial aneurysm	0.000966	0.00149	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ASAH1—intracranial aneurysm	0.000956	0.00148	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP9—intracranial aneurysm	0.000949	0.00147	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP2—intracranial aneurysm	0.000901	0.00139	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TIMP1—intracranial aneurysm	0.000884	0.00137	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ASAH1—intracranial aneurysm	0.000849	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS3—intracranial aneurysm	0.000828	0.00128	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	0.000817	0.00126	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MMP9—intracranial aneurysm	0.000784	0.00121	CbGpPWpGaD
Sulindac—ALB—Metabolism—ASAH1—intracranial aneurysm	0.000774	0.0012	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AGER—intracranial aneurysm	0.000679	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP9—intracranial aneurysm	0.000677	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NCF1—intracranial aneurysm	0.000676	0.00105	CbGpPWpGaD
Sulindac—PTGS2—Disease—CST3—intracranial aneurysm	0.000661	0.00102	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NOS3—intracranial aneurysm	0.000657	0.00102	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EDNRA—intracranial aneurysm	0.000639	0.000988	CbGpPWpGaD
Sulindac—PTGS2—Disease—NCF1—intracranial aneurysm	0.000575	0.000889	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	0.000541	0.000837	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCL2—intracranial aneurysm	0.000533	0.000825	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—intracranial aneurysm	0.000401	0.00062	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—intracranial aneurysm	0.000398	0.000616	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL2—intracranial aneurysm	0.000315	0.000487	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—intracranial aneurysm	0.000281	0.000434	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—intracranial aneurysm	0.000251	0.000389	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—intracranial aneurysm	0.000238	0.000369	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—intracranial aneurysm	0.000225	0.000348	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—intracranial aneurysm	0.0002	0.000309	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—intracranial aneurysm	0.000177	0.000274	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—intracranial aneurysm	0.000161	0.00025	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—intracranial aneurysm	0.000113	0.000175	CbGpPWpGaD
